266 related articles for article (PubMed ID: 18725991)
1. The elusive physiologic role of Factor XII.
Schmaier AH
J Clin Invest; 2008 Sep; 118(9):3006-9. PubMed ID: 18725991
[TBL] [Abstract][Full Text] [Related]
2. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.
Maas C; Govers-Riemslag JW; Bouma B; Schiks B; Hazenberg BP; Lokhorst HM; Hammarström P; ten Cate H; de Groot PG; Bouma BN; Gebbink MF
J Clin Invest; 2008 Sep; 118(9):3208-18. PubMed ID: 18725990
[TBL] [Abstract][Full Text] [Related]
3. Factor XII in coagulation, inflammation and beyond.
Didiasova M; Wujak L; Schaefer L; Wygrecka M
Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
Schousboe I
Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
[TBL] [Abstract][Full Text] [Related]
5. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
Schmaier AH
J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
[TBL] [Abstract][Full Text] [Related]
6. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
[TBL] [Abstract][Full Text] [Related]
7. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
[TBL] [Abstract][Full Text] [Related]
9. FXII.
Fuhrer G; Gallimore MJ; Heller W; Hoffmeister HE
Blut; 1990 Nov; 61(5):258-66. PubMed ID: 2271772
[TBL] [Abstract][Full Text] [Related]
10. In vivo roles of factor XII.
Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of factor XII.
Tans G; Rosing J
Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
[TBL] [Abstract][Full Text] [Related]
12. Novel roles for factor XII-driven plasma contact activation system.
Müller F; Renné T
Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
[TBL] [Abstract][Full Text] [Related]
13. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
15. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
Schmaier AH
Int Immunopharmacol; 2008 Feb; 8(2):161-5. PubMed ID: 18182220
[TBL] [Abstract][Full Text] [Related]
16. Factor XII truncation accelerates activation in solution.
de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
[TBL] [Abstract][Full Text] [Related]
17. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
[TBL] [Abstract][Full Text] [Related]
18. The contact activation system: biochemistry and interactions of these surface-mediated defense reactions.
Colman RW; Schmaier AH
Crit Rev Oncol Hematol; 1986; 5(1):57-85. PubMed ID: 3633772
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in factor XII structure and function.
Shamanaev A; Litvak M; Gailani D
Curr Opin Hematol; 2022 Sep; 29(5):233-243. PubMed ID: 35916558
[TBL] [Abstract][Full Text] [Related]
20. Competitive-protein adsorption in contact activation of blood factor XII.
Zhuo R; Siedlecki CA; Vogler EA
Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
